ISPOR Polish Chapter Accomplishments and plans for 2007/2008.

Slides:

Advertisements

Similar presentations

STUDENTS PERSPECTIVE ON TRAINING PROGRAMS Joanna Rozynska GSSR, Institute of Philosophy and Sociology Polish Academy of Science 8th Global Forum of Bioethics,

Advertisements

1 HAI conference Medicines for Europe and the World Setting priorities: missing the point A rational medicines policy for Europe A rational.

The critical role of Evolving Information Systems and the need for Standardised Coding.

4th Annual Investor Conference May 16, 2001 HEALTH PLANS DIVISION Panel Discussion: Contributing Value to Cost of Care.

RESEARCHERS‘ ACCESS TO HEALTH DATA – FACTS AND CHALLENGES Metka Zaletel National Institute of Public Health 24 March 2015.

International Society for Pharmacoeconomics and Outcomes Research updated June 2010

GS1 standards – advantages and barriers in the produce of medicine Bratislava, 20. September 2007 Peter Vavro Logistics manager, Zentiva, a.s.

MOSCOW PHARMACEUTICAL SOCIETY MOSCOW PHARMACEUTICAL SOCIETY REGIONAL NONCOMMERCIAL ORGANIZATION MPhS ANNUAL REPORT 2014.

“Hospital Information System: A Transition to a Health Information System” Kiki Tsitoyanni Presales Manager Soren Hayrabedyan Consultant H-SYSTEMS, Health.

ISPOR CHAPTERS: CENTRAL & EASTERN EUROPE Czech Chapter Poland Chapter Russia Chapter Serbia Chapter Slovakia Chapter Turkish SCP Chapter + Israel Chapter.

The European Health Care Information and Clearing Centre Jiří Kofránek, Petr Zinek, Petr Sláma Charles University, Prague & Ministry of Health, Czech Republic.

3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.

“Generic Medicines in the Taiwanese and German Legal Systems” 03 June 2011 in Taipei, Taiwan Role of Generics in the German Health Care System Financial.

Situation analysis in Kyrgyzstan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.

Facts and Figures 2008 Medicines and Health Care The Norwegian Association of Pharmaceutical Manufacturers (LMI)

European Commission Dialogue-Innovation-Future An experience of the Pharmaceutical Forum Dr Stefaan Van der Spiegel, MD Competitiveness in the Pharmaceuticals.

18th Symposium of the Central and East European Chambers of Physicians Professional self-government of physicians in Poland national report Konstanty Radziwill.

The Truth About the Drug Companies Marcia Angell, M.D.

The Migraine management in Turkey Mustafa Ertaş Department of Neurology Istanbul Faculty of Medicine.

The competition between innovative and generic pharmaceutical companies intensified in the last decades. The models created by innovative pharmaceutical.

International Research Project on Financing Quality in Healthcare InterQuality Prof. dr hab. Tomasz Hermanowski Medical University of Warsaw.

ISPOR POLAND CHAPTER Polish Society of Pharmacoeconomics (PTFe )

MeDi Access Technology & Innovation Colombia. OUR IDEA : MeDi Access The Problem: the difficulty that people have in order to be able to access properly.

Tony, Yen-Huei Tarn, M.S., Ph.D. President, TaSPOR Introduction of Taiwan Society for Pharmacoeconomics and Outcomes Research (TaSPOR) ISPOR 2ND ASIA-PACIFIC.

Pharmaceutical Pricing & Reimbursement Information ÖBIG Warsaw 29 October List of reimbursable pharmaceuticals PPRI Project Christine Leopold Gesundheit.

1/7 Are Patients Today Sufficiently Informed? Right and Ethics 10 October 2007.

Pharmaceutical Pricing & Reimbursement Information ÖBIG Warsaw 29 October Financing of expensive pharmacotherapies PPRI Project Christine Leopold.

Response to the crisis - Lithuanian way. Dynamics of Compulsory Health Insurance Fund Budget and Gross Domestic Product (GDP) from 1998 to 2010.

EHR stakeholder workshop – 11th October EHR integration for clinical research: Legal & Privacy issues Mats Sundgren – AstraZeneca Petra Wilson -

The Worth of Health Care By Gerald A. Doeksen Regents Professor and Director National Center for Rural Health Works Presentation at Virginia College of.

Applying a Gold Standard to Our Health Care System: The Institute of Medicine and the Affordable Care Act Peter Mahr, MD October 13, 2015.

A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE EPF Annual General Meeting 19 May 2010 EPF Annual General Meeting 19 May 2010.

Tartu University Hospital - Flagship of Estonian medicine Erkki Leego - IT director (1/11) eHealth initiatives in Estonia. Baltic IT&T 2004 Forum

Pharmaceutical Pricing & Reimbursement Information ÖBIG Warsaw 29 October European cooperation - PPRI PPRI Project Christine Leopold Gesundheit Österreich.

Topic 3A SEMANTIC INTEROPERABILITY: REUSE OF EHR DATA Mats Sundgren.

System-Wide Strategies for Controlling Cost in the Private Sector Deborah Chollet Senior Fellow, Mathematica Policy Research and The Robert Wood Johnson.

“Supporting the Industry through Communication” The pharmaceutical industry is committed to the research, development, quality manufacturing and logistics.

By: Nicole Giardina. History of AMA AMA was founded on May 7, 1847 by Nathan Smith Davis. The meeting to create the AMA was held in the Academy of Natural.

Pharmaceutical Pricing & Reimbursement Information ÖBIG Warsaw 29 October System of counting reimbursement costs by public payers PPRI Project Christine.

2010 ISPOR Board of Directors Open Meeting ISPOR Shanghai Chapter Interim President Wen Chen, Ph.D., Professor.

Using Australian Clinical Sites – Challenges for International Sponsors Prof A J (Tony) Webber Clinical Network Services Pty Ltd Brisbane, Australia.

Source: Kaiser Family Foundation analysis of National Health Expenditure (NHE) Historical ( ) data from Centers for Medicare and Medicaid Services,

State Prescription Drug Purchases. Pricing Standards. Initiative Statute. Jeffrey S. Hoch, PhD Professor, Department of Public Health Sciences Associate.

                 HTA: political and ethical perspectives Presentation to Forum on Pharmaceutical Policy in the Enlarged Europe at 7 th.

Source: National Association of Health Underwriters Education Foundation Value-based Insurance Design 1.

M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.

The Czech Health System – its Presence and Future

Understanding Health Systems: The Organization of

An Introduction to Health Care and Health Policy in the United States

Growth in prescription spending had slowed, but increased rapidly in 2014 and 2015

Per Enrollee Growth in Medicare Spending and Private Health Insurance Premiums (for Common Benefits), NOTE: Per enrollee includes primary.

An Economic Perspective

Cooperation for Better Regulation

Geriatric Medicine Society

DOJ Pharmaceutical Prosecutions

Developing a Strategic Reimbursement Plan

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Harmonization for Patient Centered Universal Health Coverage

HEALTHCARE INNOVATION FORUM 2018

Trends in the Overall Health Care Market

Admin. & Net Cost of Private Health Insurance

Health Care and Population

Chart 1.10: Total Prescription Drug Spending, 1980 – 2014(1)

Growth in prescription spending had slowed, but increased rapidly in 2014 and 2015

Physician/ Clinical Services Other Personal Health Care

Skin in the Game: How Putting Yourself First Today Will Revolutionize Healthcare Tomorrow —John Hammergren (CEO, McKesson) & Phil Harkins.

Private Insurance 2008–2012: Change in Average Use and Prices

Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.

MOBILE TECHNOLOGY Mobile technology is a form of technology that is mostly used in cellular communication and other related aspects. It uses a form of.

Situation analysis in Kyrgyzstan

Presentation transcript:

ISPOR Polish Chapter Accomplishments and plans for 2007/2008

2007 ISPOR Polish Chapter T. Hermanowski ISPOR Central and Eastern European Forum 130 Polish Chapter Members Health Service and Government - 46% Pharmaceutical Industry - 30% Medical University Students- 23% Legal offices- 1%

2007 ISPOR Polish Chapter T. Hermanowski ISPOR Central and Eastern European Forum Plans for 2007/2008 Vth International Scientific Conference of ISPOR Polish Chapter, Warsaw, December 4-5, 2007, –keynote speaker prof. Michael Drummond; „ Tansferability of Cost-Effectivness Data between Countries” –20-30 original presentations and posters –visitors from other ISPOR CEE Chapters Code of Ethics of ISPOR Polish Chapter adopted by 2007 Annual Meeting International questionnare-based study; Patient- centered reimbursement systems in CEE – perspectives of development

2007 ISPOR Polish Chapter T. Hermanowski ISPOR Central and Eastern European Forum Patient-centered reimbursement systems in CEE perspectives of development Pricing systems (legal foundations, types of prices, price level and dynamics) Health Insurance: public/private Reimbursement of outpatients and hospital medicines in public/private sector Reimbursement/Pricing connection

2007 ISPOR Polish Chapter T. Hermanowski ISPOR Central and Eastern European Forum Patient-centered reimbursement systems in CEE perspectives of development Identification of main stakeholders, Patients access to innovation, co-payment level Medical prescription management Drug information systems, pharmaceutical care